What is the difference between Raloxifene Hydrochloride and Toremifene Citrate?

Raloxifene Hydrochloride and Toremifene Citrate are both SERMs, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Raloxifene Hydrochloride and Toremifene Citrate be used for the same conditions?

Both medications are prescribed for overlapping indications including reduction of the risk of recurrence of breast cancer and one or more first-degree relatives with breast cancer. Always verify with your prescriber and the current FDA label before switching.

Is Raloxifene Hydrochloride the same as Fareston?

No. Raloxifene Hydrochloride (Raloxifene Hydrochloride) and Fareston (Toremifene Citrate) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Raloxifene Hydrochloride or Toremifene Citrate?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Raloxifene Hydrochloride to Toremifene Citrate?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Raloxifene Hydrochloride vs Toremifene Citrate

Compare Raloxifene Hydrochloride (Raloxifene Hydrochloride) and Toremifene Citrate (Fareston), clinical data, side effects, and patient experiences.

Raloxifene Hydrochloride

Raloxifene Hydrochloride · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

reduction of the risk of recurrence of breast cancer

one or more first-degree relatives with breast cancer

or a 5-year predicted risk of breast cancer ≥1.66% (based on the modified Gail model). Among the factors included in the modified Gail model are the following: current age

number of first-degree relatives with breast cancer

OralTablet

Toremifene Citrate

Fareston · SERM

How it works

12.1 Mechanism of Action Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activit...

Approved for

See full prescribing information

OralTablet

Quick Comparison

Raloxifene HydrochlorideToremifene Citrate

Drug Class

SERM

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Raloxifene Hydrochloride

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

Toremifene Citrate

Fatigue

1-10%

Peripheral Edema

1-10%

Fever

1-10%

General Unwellness

1-10%

FDA Warnings

Raloxifene Hydrochloride

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism : Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1) Death Due to Stroke : Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

Toremifene Citrate

5 WARNINGS AND PRECAUTIONS Prolongation of the QT Interval ( 5
3 ) Risk of Uterine Malignancy ( 5
Prolongation of the QT interval can result in a type of ventricular tachycardia called Torsade de pointes, which may result in syncope, seizure, and/or death
In patients at increased risk, electrocardiograms (ECGs) should be obtained at baseline and as clinically indicated [see Drug Interactions (7

Clinical Trial Data

No head-to-head clinical studies found for Raloxifene Hydrochloride vs Toremifene Citrate.

Raloxifene Hydrochloride vs Toremifene Citrate: What You Should Know

Key Differences

Both Raloxifene Hydrochloride and Toremifene Citrate belong to the SERM class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Raloxifene Hydrochloride carries 4 FDA warnings. Toremifene Citrate carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Raloxifene Hydrochloride vs Tamoxifen Citrate→Raloxifene vs Raloxifene Hydrochloride→Tamoxifen Citrate vs Toremifene Citrate→Raloxifene vs Toremifene Citrate→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Raloxifene Hydrochloride: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Toremifene Citrate: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Raloxifene Hydrochloride vs Toremifene Citrate

Compare Raloxifene Hydrochloride (Raloxifene Hydrochloride) and Toremifene Citrate (Fareston), clinical data, side effects, and patient experiences.

Raloxifene Hydrochloride

Raloxifene Hydrochloride · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

reduction of the risk of recurrence of breast cancer

one or more first-degree relatives with breast cancer

or a 5-year predicted risk of breast cancer ≥1.66% (based on the modified Gail model). Among the factors included in the modified Gail model are the following: current age

number of first-degree relatives with breast cancer

OralTablet

Toremifene Citrate

Fareston · SERM

How it works

12.1 Mechanism of Action Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activit...

Approved for

See full prescribing information

OralTablet

Quick Comparison

Raloxifene HydrochlorideToremifene Citrate

Drug Class

SERM

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Raloxifene Hydrochloride

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

Toremifene Citrate

Fatigue

1-10%

Peripheral Edema

1-10%

Fever

1-10%

General Unwellness

1-10%

FDA Warnings

Raloxifene Hydrochloride

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism : Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1) Death Due to Stroke : Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

Toremifene Citrate

5 WARNINGS AND PRECAUTIONS Prolongation of the QT Interval ( 5
3 ) Risk of Uterine Malignancy ( 5
Prolongation of the QT interval can result in a type of ventricular tachycardia called Torsade de pointes, which may result in syncope, seizure, and/or death
In patients at increased risk, electrocardiograms (ECGs) should be obtained at baseline and as clinically indicated [see Drug Interactions (7

Clinical Trial Data

No head-to-head clinical studies found for Raloxifene Hydrochloride vs Toremifene Citrate.

Raloxifene Hydrochloride vs Toremifene Citrate: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Raloxifene Hydrochloride: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Toremifene Citrate: DailyMed label · FAERS adverse events · ClinicalTrials.gov